Black Diamond Therapeutics (BDTX) Short Interest Ratio & Short Volume $2.89 +0.15 (+5.47%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Black Diamond Therapeutics Short Interest DataBlack Diamond Therapeutics (BDTX) has a short interest of 7.32 million shares. This marks a 5.93% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.2, indicating that it would take 6.2 days of the average trading volume of 824,889 shares to cover all short positions.Current Short Interest7,320,000 sharesPrevious Short Interest6,910,000 sharesChange Vs. Previous Month+5.93%Dollar Volume Sold Short$24.89 millionShort Interest Ratio6.2 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares56,505,000 sharesPercentage of Shares Shorted12.95%Today's Trading Volume415,776 sharesAverage Trading Volume824,889 sharesToday's Volume Vs. Average50% Short Selling Black Diamond Therapeutics? Sign up to receive the latest short interest report for Black Diamond Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBDTX Short Interest Over TimeBDTX Days to Cover Over TimeBDTX Percentage of Float Shorted Over Time Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Black Diamond Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20247,320,000 shares $24.89 million +5.9%N/A6.2 $3.40 9/30/20246,910,000 shares $30.06 million +17.9%N/A6.2 $4.35 9/15/20245,860,000 shares $36.27 million -3.5%N/A5.2 $6.19 8/31/20246,070,000 shares $37.03 million +1.0%N/A9.4 $6.10 8/15/20246,010,000 shares $29.93 million +35.4%N/A9.4 $4.98 7/31/20244,440,000 shares $27.04 million -6.1%N/A6.4 $6.09 Get the Latest News and Ratings for BDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Black Diamond Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/20244,730,000 shares $28.47 million +47.4%N/A6.2 $6.02 6/30/20243,210,000 shares $14.96 million +8.5%N/A4.1 $4.66 6/15/20242,960,000 shares $17.67 million +13.0%N/A4.4 $5.97 5/31/20242,620,000 shares $12.52 million +22.4%N/A3.9 $4.78 5/15/20242,140,000 shares $11.64 million +7.0%N/A3.3 $5.44 4/30/20242,000,000 shares $11.14 million +13.6%N/A3 $5.57 4/15/20241,760,000 shares $9.19 million -13.7%N/A2.8 $5.22 3/31/20242,040,000 shares $10.34 million +12.7%N/A3.4 $5.07 3/15/20241,810,000 shares $8.67 million +1.7%N/A3.1 $4.79 2/29/20241,780,000 shares $9.16 million -5.3%N/A3.1 $5.15 2/15/20241,880,000 shares $9.51 million -21.7%N/A3.5 $5.06 1/31/20242,400,000 shares $9.22 million -33.0%N/A4.5 $3.84 1/15/20243,580,000 shares $10.67 million -1.1%N/A7.9 $2.98 12/31/20233,620,000 shares $10.17 million -0.6%N/A7.1 $2.81 12/15/20233,640,000 shares $9.86 million +6.4%N/A7 $2.71 11/30/20233,420,000 shares $8.00 million +1.8%N/A6.2 $2.34 11/15/20233,360,000 shares $7.56 million +0.3%N/A6 $2.25 10/31/20233,350,000 shares $6.30 million +12.8%9.8%6.2 $1.88 10/15/20232,970,000 shares $6.80 million +24.3%8.7%5.6 $2.29 9/30/20232,390,000 shares $6.86 million +68.3%7.0%3.9 $2.87 9/15/20231,420,000 shares $5.04 million +24.6%4.1%0.3 $3.55 8/31/20231,140,000 shares $3.84 million +7.6%3.2%0.3 $3.37 8/15/20231,060,000 shares $3.36 million +1.9%2.9%0.3 $3.17 7/31/20231,040,000 shares $3.88 million -67.3%4.7%0.3 $3.73 7/15/20233,180,000 shares $15.42 million -38.4%14.4%0.8 $4.85 6/30/20235,160,000 shares $26.06 million +166.0%23.4%1.3 $5.05 6/15/20231,940,000 shares $4.07 million No Change8.4%31.3 $2.10 5/31/20231,940,000 shares $3.61 million No Change8.4%22.7 $1.86 5/15/20231,940,000 shares $3.74 million -1.5%8.4%24.1 $1.93 4/30/20231,970,000 shares $2.82 million No Change8.6%24.1 $1.43 4/15/20231,970,000 shares $2.94 million -1.5%8.6%22.6 $1.49 3/31/20232,000,000 shares $3.78 million -1.5%8.7%17.3 $1.89 3/15/20232,030,000 shares $3.41 million +3.1%8.8%13.5 $1.68 2/28/20231,970,000 shares $3.49 million -1.0%8.6%14.6 $1.77Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… 2/15/20231,990,000 shares $5.23 million No Change8.7%14.6 $2.63 1/31/20231,990,000 shares $5.97 million -2.0%8.7%13.3 $3.00 1/15/20232,030,000 shares $5.36 million -2.4%8.9%9.6 $2.64 12/30/20222,080,000 shares $3.74 million +5.6%9.1%10 $1.80 12/15/20221,970,000 shares $2.96 million No Change8.6%10.5 $1.50 11/30/20221,970,000 shares $4.16 million -2.5%8.6%11.1 $2.11 11/15/20222,020,000 shares $4.79 million -2.4%8.8%11.2 $2.37 10/31/20222,070,000 shares $4.78 million -7.2%9.1%11.3 $2.31 10/15/20222,230,000 shares $2.83 million +6.2%9.8%14.9 $1.27 9/30/20222,100,000 shares $3.55 million No Change9.2%15.8 $1.69 9/15/20222,100,000 shares $5.50 million -3.7%9.2%11.1 $2.62 8/31/20222,180,000 shares $6.95 million -0.5%9.5%10.7 $3.19 8/15/20222,190,000 shares $8.78 million -4.0%9.6%9.7 $4.01 7/31/20222,280,000 shares $7.98 million -8.1%10.0%9.6 $3.50 7/15/20222,480,000 shares $7.79 million -5.0%10.9%9.8 $3.14 6/30/20222,610,000 shares $6.42 million -18.2%11.4%9.3 $2.46 6/15/20223,190,000 shares $6.73 million -9.9%14.0%11.5 $2.11 5/31/20223,540,000 shares $5.98 million -1.9%15.5%15.1 $1.69 5/15/20223,610,000 shares $6.39 million +1.4%15.8%15.1 $1.77 4/30/20223,560,000 shares $8.65 million +8.5%15.6%14.6 $2.43 4/15/20223,280,000 shares $11.18 million +3.8%14.4%12.1 $3.41 3/31/20223,160,000 shares $8.75 million -1.6%13.8%5.5 $2.77 3/15/20223,210,000 shares $8.86 million -1.8%14.1%5.5 $2.76 2/28/20223,270,000 shares $10.27 million +3.2%14.3%5.5 $3.14 2/15/20223,170,000 shares $12.01 million -5.9%13.9%5.3 $3.79 1/31/20223,370,000 shares $14.05 million -8.4%14.8%5.7 $4.17 1/15/20223,680,000 shares $15.60 million +19.5%14.8%6.7 $4.24 12/31/20213,080,000 shares $16.42 million +2.7%12.4%5.8 $5.33 12/15/20213,000,000 shares $15.93 million -3.9%12.1%12.9 $5.31 11/30/20213,120,000 shares $18.72 million +1.3%12.6%13.8 $6.00 11/15/20213,080,000 shares $23.56 million -5.5%12.4%13.5 $7.65 10/29/20213,260,000 shares $24.97 million -12.6%13.0%13.7 $7.66 10/15/20213,730,000 shares $30.51 million -4.1%14.9%14.8 $8.18 9/30/20213,890,000 shares $32.91 million -7.8%15.5%14.4 $8.46 9/15/20214,220,000 shares $40.68 million -0.5%16.8%13.5 $9.64 8/31/20214,240,000 shares $42.82 million +2.9%16.8%9.9 $10.10 8/13/20214,120,000 shares $38.23 million +2.0%16.4%7.4 $9.28 7/30/20214,040,000 shares $38.62 million +5.5%16.1%5.1 $9.56 7/15/20213,830,000 shares $38.45 million -1.8%15.2%4.9 $10.04 6/30/20213,900,000 shares $47.54 million -3.0%15.5%4.9 $12.19 6/15/20214,020,000 shares $51.34 million -7.2%16.0%5.3 $12.77 5/28/20214,330,000 shares $56.81 million -6.9%17.2%6.4 $13.12 5/14/20214,650,000 shares $123.50 million -0.9%18.5%8 $26.56 4/30/20214,690,000 shares $127.99 million No Change18.7%14.1 $27.29 4/15/20214,690,000 shares $116.45 million +1.1%17.3%11.6 $24.83 3/31/20214,640,000 shares $104.72 million +27.1%17.1%10 $22.57 3/15/20213,650,000 shares $96.69 million +1.4%13.5%7.9 $26.49 2/26/20213,600,000 shares $101.95 million +2.3%13.3%8.1 $28.32 2/12/20213,520,000 shares $98.21 million +4.5%13.0%7.9 $27.90 1/29/20213,370,000 shares $81.55 million +3.1%12.5%7.7 $24.20Crypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. 1/15/20213,270,000 shares $93.59 million No Change12.1%8.9 $28.62 BDTX Short Interest - Frequently Asked Questions What is Black Diamond Therapeutics' current short interest? Short interest is the volume of Black Diamond Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 7,320,000 shares of BDTX short. Learn More on Black Diamond Therapeutics' current short interest. What is a good short interest ratio for Black Diamond Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BDTX shares currently have a short interest ratio of 6.0. Learn More on Black Diamond Therapeutics's short interest ratio. Is Black Diamond Therapeutics' short interest increasing or decreasing? Black Diamond Therapeutics saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 7,320,000 shares, an increase of 5.9% from the previous total of 6,910,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Black Diamond Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Black Diamond Therapeutics: Compugen Ltd. (1.74%), Inhibrx, Inc. (8.89%), iTeos Therapeutics, Inc. (13.60%), C4 Therapeutics, Inc. (9.59%), Stoke Therapeutics, Inc. (12.90%), Entrada Therapeutics, Inc. (7.64%), Tango Therapeutics, Inc. (15.42%), Acelyrin, Inc. (8.00%), Humacyte, Inc. (17.04%), Exscientia plc (2.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Black Diamond Therapeutics stock? Short selling BDTX is an investing strategy that aims to generate trading profit from Black Diamond Therapeutics as its price is falling. BDTX shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Black Diamond Therapeutics? A short squeeze for Black Diamond Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BDTX, which in turn drives the price of the stock up even further. How often is Black Diamond Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BDTX, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Compugen Short Squeeze Inhibrx Short Squeeze iTeos Therapeutics Short Squeeze C4 Therapeutics Short Squeeze Stoke Therapeutics Short Squeeze Entrada Therapeutics Short Squeeze Tango Therapeutics Short Squeeze Acelyrin Short Squeeze Humacyte Short Squeeze Exscientia Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BDTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
